MINISTRY OF RESEARCH, TECHNOLOGY, AND...

32
NATIONAL RESEARCH LANDSCAPE AND STRATEGY FOR RESEARCH DEVELOPMENT Presented in the 1’st National Forum on Management of Indonesian Research Institution Yogyakarta, May 15, 2017 Muh. Dimyati Director General of Strengthening for Research and Development MINISTRYOF RESEARCH, TECHNOLOGY, AND HIGHER EDUCATION REPUBLIC OF INDONESIA

Transcript of MINISTRY OF RESEARCH, TECHNOLOGY, AND...

Page 1: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

NATIONAL RESEARCH LANDSCAPE ANDSTRATEGY FOR RESEARCH DEVELOPMENT

Presented inthe 1’stNationalForumon Management of IndonesianResearch InstitutionYogyakarta,May15,2017

Muh.DimyatiDirector Generalof Strengthening for Research and Development

MINISTRYOFRESEARCH,TECHNOLOGY,ANDHIGHEREDUCATIONREPUBLICOFINDONESIA

Page 2: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

NEWSUPDATE

“Iwanttoemphasizeinvestmentineducationthroughtheprovisionofhighereducationscholarshipsand

research,isaninvestmentthatisveryimportantforourcountrytoadvanceinthefuture”,saidJokowi inalimitedmeetingonLPDPatthePresidentialOffice,

PresidentialPalaceComplex,Jakarta.(Kompas,Tuesday,February7,2017)

“Wehope theseweeksmaybecompletedbythePresidentialDecreeonProcurementofGoodsandServices,hopefully”,saidVivePresidentJusuf Kalla (Berita Satu,April4,2017)

ThisisanexampleofaconcernofPresidentandVicePresidentrelatedresearchinfrastructuresorinstruments.

Page 3: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

R&D MUST BE ORIENTED TO NATION COMPETITIVENESS à

PUBLIC WELFARE

3SO IT IS NOTresearch for the sake of research

Page 4: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

Sumber: WEF 2015 & 2016 page 28

COMPETITIVENESS 2015-2016 37 (4,5) COMPETITIVENESS 2016-2017 41 (4,5)

Pillar/Sub Pillar Rank Score Pillar/Sub Pillar Rank Score

12th Innovation 30 3,9 Innovation 31 4,0

Capacity for Innovation 30 4,7 Capacity for Innovation 32 4,7

Quality of scientific research institutions 41 4,3 Quality of scientific research institutions

41 4,4

Company spending on R&D 24 4,2 Company spending on R&D 26 4,4

University-industry collaboration in R&D

30 4,5 University-industry collaboration in R&D

28 4,4

Gov’t procurement of advanced tech products.

13 4,2 Gov’t procurement of advanced tech products.

12 4,3

Availability of scientists and engineers 34 4,6 Availability of scientists and engineers 38 4,5

PCT patents, applications/million pop.*

102 0,1 PCT patents, applications/million pop.*

99 0,1

Switzerland 1(5,76) à1(5,81); Singapor 2(5,68) à2(5,72); Malaysia 18 (5,23) à 25(5,16); Thailand 32 (4,64) à 34(4,64);

Indonesia 37 (4,52) à 41(4,52); Philipines 47 (4,39) à 57(4,36); Vietnam 56 (4,30) à60(4,31);

MOST OF THE SCORE OF INNOVATION ARE INCREASED

Page 5: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

NATIONALR&DPERFORMANCE

…... Inthepositionandabilityofthecountryasnow,Indonesiashoulddaretochoosethefocus…

Target 2015 2020 2015

Input HRD

Number of Human Resources inS&T every million people 1,071 1,600 8,000

Ratio of Human Resource Candidate of S&T (%) 5.6 20 90

Input Budget

Government Budget Allocation Ratio for R&D/ GDP (%) 0.15 0.21 1.05

Ratio of Gross Research and Development / GDP(%) 0.20 0.84 4.20

OutputProductivity Human Resources in S&T (global indexed publications / 100 Human Resources in S&T)

2 4 18

Outcome Multy Factor Productivity (%) 16.7 20 60

Position of South Korea

Year 2015“as a benchmarking”

Position of Indonesia 2015And Target 2020

Note: In 2016 total Government Expenditure for R&D Rp 17,8 Billion, it means GERD = Rp 22,2 Billion(Source: Analysis from many sources of presentations)

Page 6: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

R&DSOURCEOFINNOVATIONResearch objectivesà create innovation and invention.

Whether research results can be categorized as invention or innovation is determined by the relevant global

community, through a peer review mechanism in a community-recognized scientific journal. So the journal is

not just a dissemination tool, but as a filter on the substance of research results.

Encourage lecturer-research productivity.

Page 7: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

THREE R&D INDICATORS

(Publication, IPR, Prorotype)B

Page 8: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

Data Publikasi Indonesia 2016 dikutip 5 April 2017; Sum,ber Scopus

PERFORMANCE OF PUBLICATIONS OF UNIVERSITY IN INDONESIA

Source IPI, April 5, 2017NATIONAL PUBLICATION

8

11.526 documents(status May 13, 2017

(status April, 2017

Page 9: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

11.942Dosen

INTERNATIONAL PUBLICATIONS(STATUS MARCH 24, 2017)

28.561 19.990 14.181 11.472 5.123 2.382

Page 10: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

IPRANDPROTOTYPEOFOUTPUTRESEARCH

EXAMPLE YEAR 2016.

ONLY + 6% ( OF

15.480 GRANTED) OF OUTPUT

RESEARCH OF SIMLITABMAS

WITH TRL >= 7

(SOURCE: DATA 2016)

Page 11: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

POTENTIAL FOR PUBLICATION

Sumber: Diolah dari berbgaia Data, 2016

STATUSPOTENTIOAL

CONTRIBUTORS PREDICTIONS

2015 2016 2017 2019

ASISTEN AHLI 39.767 994 1.988 3.976LEKTOR 43.691 2.184 3.276 5.461

LEKTOR KEPALA 31.010 1.550 3.101 6.202GURU BESAR (PROF) 5.097 254 382 637

PENELITI PERTAMA 2.759 41 275 413PENELITI MUDA 2.868 143 286 717

PENELITI MADYA 2.666 266 399 533PENELITI UTAMA 1.041 52 78 156

MAHASISWA S3 22.156 5.000 5.000 7.156

TOTAL 151.055 10.484 14.785 25.251

Page 12: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

R&DDEVELOPMENTPOLICYANDSTRATEGYC

Page 13: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

POLICYOFR&D

1. Generalà ArrangeRIRN2017-2045;RevisePerpres 54/2010+BabPenelitian;

2. Publicationà PMK106,PermenR 69/2016,Panduan XI,PermenR 20/2017,PermenR44/2015,SINTA;

3. IPRà UU28/2014Hak Cipta (Copyrights);UU15/2001Merek;UU31/2000Desain Industri;UU32/2000Desain Tataletak Sirkuit;UU30/2000Rahasia Dagang;UU13/2016,….

Page 14: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

POLICYOFR&D

3. continue….... PP45/2016,PMK72/2015dan PMK06/2016Royalti ASN;

4. Prototypeà PermenR 42/2016;5. PublicationInsentives (PPII,dsb),Publication

WritingAssistance,Jurnal Mangement Assistance;6. EstablishingISF(DIPI),LPDP(backupResearchand

Scholarship),CSR,Philanthropy;7. Cooperationwithstakeholders (NewtonFund,

Nusantara-France,USAIDSHERA,Satreps,JSPS,KSI);8. AttemptstoIncreaseResearchandInfrastructure

Funds.

Page 15: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

ACHIEVEMENTSTRATEGYTARGETINDICATORSINRIRN2017-2045

SASARAN 2015 2019 2024 2029 2034 2039 2044MFP 16,7 20,0 30,0 40,0 50,0 60,0 70,0

PRODUKTIVITASPENELITI

2 4 7 10 14 18 22

SDM PENELITI 1.071 1.600 3.200 4.800 6.400 8,000 9.600

SDM KANDIDAT PENELITI

5,6 20 40 60 80 90 100

GERD/PDB 0,20 0,84 1,68 2,52 3,36 4,20 5,04

GBAORD/PDB 0,15 0,21 0,42 0,63 0,84 1,05 1,26

out

com

eou

put

inpu

tS

DM

inpu

tan

ggar

anAchievementInputIndicatorStrategies:

1. ManagementofS&THUMANRESOURCES,and2. ImprovementofNationalResearchFUNDINGSYSTEM.

AchievementofOutputIndicatorStrategy:AnincreasingnumberofreputableinternationalSCIENTIFICPUBLICATIONS,reflectingtheabilitytocreatescience-based

inventionsasupstreamfrominnovationproductswithhigheconomicvalue.

PROTOTYPE,INTELLECTUALPROPERTY,DOUBLETAXDEDUCTION;

RESEARCHFOCUS

StrategiesforAchieving ImpactIndicators:Improvementofscience-basedcreativeindustriestoencouragemulti-

factorproductivity thatreflectsthecontributionofscience-based innovation innationaleconomicgrowth.

Page 16: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

SASARAN 2015 2019 2024 2029 2034 2039 2044MFP 16,7 20,0 30,0 40,0 50,0 60,0 70,0

PRODUKTIVITASPENELITI

2 4 7 10 14 18 22

SDM PENELITI 1.071 1.600 3.200 4.800 6.400 8,000 9.600

SDM KANDIDAT PENELITI

5,6 20 40 60 80 90 100

GERD/PDB 0,20 0,84 1,68 2,52 3,36 4,20 5,04

GBAORD/PDB 0,15 0,21 0,42 0,63 0,84 1,05 1,26

out

com

eou

put

inpu

tS

DM

inpu

tan

ggar

an

RELATEDPOLICYSTRATEGYOFRESEARCHPRODUCTIVITY:v Acceleratedimprovement ofhighereducationqualityandresearch,v Deregulationofintellectualpropertymaintenance,v Specialfundingschemesfordissemination (globalindexedpublications),v Refreshment(researchvisitandguestresearcher),andotherstrategies.

POLICYIMPLEMENTATIONSTRATEGYMFP:v Theestablishmentofincubationcentersinvariousregionsaccording

totheirpotential,v Implementationoftheroyaltysystemforgovernmentinnovators, and

v Incentivesfortheestablishment ofaventurecompanyandotherstrategies.

ACHIEVEMENTSTRATEGYTARGETINDICATORSINRIRN2017-2045

Page 17: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

ATTACHMENT

KEMENTERIANRISET,TEKNOLOGI,DANPENDIDIKANTINGGIREPUBLIKINDONESIAD

Page 18: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

FOCUSOFPERMENRISTEKDIKTI:DETERMINATIONOFFOCUSRESEARCH

1. Pangan - Pertanian

2. Energi - Energi Baru dan Terbarukan

3. Kesehatan - Obat

4. Transportasi

5. Teknologi Informasi dan Komunikasi (TIK)

6. Pertahanan dan Keamanan

7. Material Maju

8. Kemaritiman

9. Kebencanaan

10. Sosial Humaniora – Seni Budaya –Pendidikan

1. FOOD

2. ENERGY

3. HEALTH

4. TRANSPORTATION5. ENGINEERING

PRODUCTS6. DEFENCE

7. MARITIME

8. SOCIAL HUMANITY

FIELDOFRESEARCHRIRNFOCUS OF RESEARCH PRN 2017 -- 2019

Ditetapkantiap 5 tahun

Page 19: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

FOCUS RESEARCH OF HEALTH-MEDICINE UP TO 2019

q Mastery of major vaccine production (hepatitis, dengue)

q The mastery of stem cells (stem cells)

q Mastery of biosimilar products and blood products

q Development of in vivo diagnostic (IVD) for the detection of infectious diseases

q Development of in vivo diagnostic (IVD) for degenerative diseases

q Development of electromedic tools

q Development of phyopharmaca based on local resources

q Chemical raw materialsq Saintifikasi herbal & herbal, natural

pigment production technology

FOCUS

THEMA

TOPIC TOPIC

TOPIC

Page 20: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

20

167

64

25 22

56

310

511

0

100

200

300

400

500

600

Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka Herbal/Jamu Jamu

Jum

lah

Ris

et

TREND RESEARCH DATA IN THE FIELD OF HEALTH 2012-2016

(UNIVERSITIES AND RESEARCH INSTITUTE)

HEALTH AND MEDICINE

Sumber: Simlitabmas dan Insinas (Kemenristekdikti)

Page 21: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

RISET PENUGASAN

RISET SOURCE

MULTI YEARS

BERBASIS OUTPUT

REVISIONOFPERPRESPROCUREMENTOFGOODSANDSERVICES

Page 22: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

PMK NO 106/PMK.02/2016

SBK ADALAH BESARAN BIAYA

UNTUK KELUARAN

BESARAN BEAYA BERDASAR HASIL

KOMITE PENILAIAN

BATAS TERTINGGI DAN TAK DAPAT

DILAMPAUI

Page 23: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

ü PASAL 1 à Definisi SBK dan Penyelenggaraü PASAL 2à Penetapan besaran biaya oleh Komite Penilai dan/atau

Reviewerü PASAL 3 àJenis dan Penetapan Komite Penilai/ reviewer dan

anggotanyaü PASAL 4 à Persyaratan Komite Penilaiü PASAL 5 à Persyaratan Reviewerü PASAL 6 à Tugas Komite Penilai/ Reviewerü PASAL 7 à Tahapan Penilaian Proposalü PASAL 8 à Ketentuan Detail diatur dalam lampiran

PERMENRISTEKDIKTI69/2016

Page 24: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

SINTA– SCIENCE&TECHNOLGYINDEX

SCIENCE AND TECHNOLOGY INDEX(SINTA) LAUNCHED IN UGM

YOGYAKARTA, LAST JANUARY 2017

sinta.ristekdikti.go.id

Registered SINTA

> 4.125HAS BEEN

ACCECCED BY > 5,5 MILLION

USERS

Page 25: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

THENEEDOFJOURNAL

vWe need 7.817 National and International Journals.

vWe only have 471 Acredited National Journals, and 28 International (Scopus) Journals.

vWe have more than 7.641 journal meets the requirements for acreditations.

vAnd there are 1.600 journals ready to be acredited….on going process.

Sumber : Analisis, 2017

Page 26: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

PROGRAMOFJOURNALACCELERATIONv Sistem Akreditasi Jurnal Nasional (Perditjendikti 1/2014) hanya punya 2 kelas

(Kelas A dengan Nilai Akreditasi 85-100, dan Kelas B dengan Nilai 70-85).v Untuk mengakselerasi jumlah Jurnal yang dibutuhkan akan segera dibuat (TA 2017)

Sistem Grading Baru dengan 6 Kelas (Klaster), berikut:

NO KLASTER KRITERIA

1 Sinta -1 Journal accredited A with a value of 85-100, or indexed in Scopus2 Sinta -2 Journal accredited A with a value of 70-853 Sinta -3 Journals that have been self-evaluated in Arjuna and verified with a value

of 60-704 Sinta -4 Journals that have been self-evaluated in Arjuna and verified with a value

of 50-605 Sinta -5 Journals that have been self-evaluated in Arjuna and verified with a value

of 40-506 Sinta -6 Journals that have been self-evaluated in Arjuna and verified with a value

of 30-40

Page 27: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

POSITIONOFSINTAANDSCOPUSNO ITEM GROUP ELSEVIER SINTA

1 Publisher Elsevier Penerbit Jurnal Indonesia

2Dbase E-Journal(Pencarian Referen-sisampai full text)

Science Direct

1. Indonesian Scientific Journal Dbase (IJSD)

2. Indonesian Publication Index (IPI)

3 Sistem dan kebija-kan seleksi Jurnal

CSAB (Content Se-lection Advisory Board) Arjuna

4 Research Performance SCOPUS SINTA

Kemenristekdikti[Rating,Performance,and

ResearchAnalysis]5 Journal Rating

(Journal Metric) SCIMAGO

6 Reseacrh Analysis SCIVAL

Page 28: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

qRegulated by Law 28/2014 à copyrightsq The principle that Copyright is either registered or not, remains

protected, so registration is only a record.q The protection period is 70 years after the rights owner dies.q Copyright protected: Books, computer programs, pamphlets and other papers;

Materials lectures, lectures, speeches; Props for education and IP; Song or music with or without text; Drama, dance, choreography, puppetry, pantomime; Art in all forms; Architecture; Map; Batik art; Photography; Translation, commentary, adaptation, potpourri (bunga rampai), and other works of the translations (pengalihwujudan).

HAK CIPTA (COPYRIGHTS)

Page 29: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

q Regulated by Law 31/2000 on Industrial Design;q It is the appearance of a product, with 10 years protection and can

not be extended.

DESAIN INDIUSTRI (INDUSTRIAL DESIGN)

q Regulated by Law 32/2000 on Layout Design of Integrated Circuit;

DESAIN TATA LETAK SIKUIT TERPADU

Page 30: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

30

Page 31: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka

31

Penghitungan tarif ini secara progresif. Contohnya bila

nilai royalti/imbalan nya Rp 2 Milyar, maka mereka akan

dapat (40%*100Juta)+ (30%*500Juta)

+(20%*1M)+(10%*400) = Rp 430 Juta

Sumber: Dtjen Penguatan Risbang, tahun 2017

IMBALAN BAGI INVENTOR ASN (PMK 72/2015) DAN PEMULIA TANAMAN ASN (PMK 06/2016)

Page 32: MINISTRY OF RESEARCH, TECHNOLOGY, AND …fk.ugm.ac.id/wp-content/uploads/2017/05/1.1.-Dirjen-Ristek-Dikti.pdf · Vaksin Sel Punca Penyakit Infeksi Penyakit Degeneratif Fitofarmaka